Canamide | 1553451-04-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: Canamide
• 英文别名: N-(1,3-dihydroxypropan-2-yl)-2-propylpentanamide
• CAS: 1553451-04-9
• 化学式: C₁₁H₂₃NO₃
• 分子量: 217.31
• InChiKey: WUUGNCZWAKSSBO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  15
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.91
• 拓扑面积：
  69.6
• 氢给体数：
  3
• 氢受体数：
  3

文献信息

• Composition for skin external application
  申请人：DR. RAYMOND LABORATORIES, INC.

  公开号：US10987293B2

  公开（公告）日：2021-04-27

  The present invention relates to a composition for skin external application. Specifically, a composition for skin external application comprising a stably formed lamella liquid crystal phase can be provided according to the present invention. In addition, according to the present invention, the composition can provide excellent skin moisturizing and skin barrier strengthening effects upon application on the skin, as well as act effectively as an agent for a cannabinoid type 1 receptor, such that it is expected that the present invention can provide a very effective effect for treatment or improvement of skin diseases and mental disorders associated with skin diseases.

  本发明涉及一种皮肤外用组合物。具体地说，根据本发明可以提供一种皮肤外用组合物，该组合物包含稳定形成的层状液晶相。此外，根据本发明，该组合物涂抹于皮肤后可提供极佳的皮肤保湿和皮肤屏障强化效果，并可有效地作为大麻素 1 型受体的制剂，因此预计本发明可为治疗或改善皮肤疾病和与皮肤疾病相关的精神障碍提供非常有效的效果。
• ETHYLENEDIAMINETETRAACETIC ACID BIS(AMIDE) DERIVATIVES AND THEIR RESPECTIVE COMPLEXES WITH MN(II) ION FOR USE AS MRI CONTRAST AGENT
  申请人：Bracco Imaging SpA

  公开号：EP3262033B1

  公开（公告）日：2020-08-26
• COMPOSITION FOR SKIN EXTERNAL APPLICATION
  申请人：DR. RAYMOND LABORATORIES, INC.

  公开号：US20200276096A1

  公开（公告）日：2020-09-03

  The present invention relates to a composition for skin external application. Specifically, a composition for skin external application comprising a stably formed lamella liquid crystal phase can be provided according to the present invention. In addition, according to the present invention, the composition can provide excellent skin moisturizing and skin barrier strengthening effects upon application on the skin, as well as act effectively as an agent for a cannabinoid type 1 receptor, such that it is expected that the present invention can provide a very effective effect for treatment or improvement of skin diseases and mental disorders associated with skin diseases.
• [EN] COMPOSITION FOR SKIN EXTERNAL APPLICATION<br/>[FR] COMPOSITION POUR APPLICATION EXTERNE CUTANÉE<br/>[KO] 피부 외용제 조성물
  申请人：DR RAYMOND LABORATORIES INC

  公开号：WO2019172572A1

  公开（公告）日：2019-09-12

  본 발명은 피부 외용제 조성물에 관한 것이다. 구체적으로, 본 발명에 따르면 안정적으로 형성된 액정상을 포함하는 피부 외용제 조성물을 제공할 수 있다. 또한, 본 발명에 따르면 피부 도포시 우수한 피부 보습 및 피부장벽 강화 효과를 제공할 수 있음은 물론이고, 칸나비노이드1 수용체에 대한 작용제로 유효하게 작용하여 피부질환 및 피부질환으로 인해 동반되는 정신질환의 치료 또는 개선에 매우 유효한 효과를 제공할 수 있을 것으로 기대된다.